Gatz Christian, Hathazi Denisa, Münchberg Ute, Buchkremer Stephan, Labisch Thomas, Munro Ben, Horvath Rita, Töpf Ana, Weis Joachim, Roos Andreas
Institute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.
Front Neurol. 2019 Jun 14;10:562. doi: 10.3389/fneur.2019.00562. eCollection 2019.
Recessive mutations in the gene cause Marinesco-Sjögren syndrome (MSS), a rare neuropediatric disorder. MSS-patients typically present with congenital cataracts, intellectual disability, cerebellar ataxia and progressive vacuolar myopathy. However, atypical clinical presentations associated with mutations have been described over the last years; compound heterozygosity of SIL1 missense mutations even resulted in a phenotype not fulfilling the clinical diagnostic criteria of MSS. Thus, a read-out system to evaluate reliably the pathogenicity of amino acid changes in is needed. Here, we aim to provide suitable cellular biomarkers enabling the robust evaluation of pathogenicity of SIL1 mutations. Five variants including one polymorphism (p.K132Q), three known pathogenic mutations (p.V231_I232del, p.G312R, and p.L457P) and one ambiguous missense variant (p.R92W) were studied along with the wild-type proteins in Hek293 models by cell biological assays, immunoprecipitation, immunoblotting, and immunofluorescence as well as electron microscopy. Moreover, the SIL1-interactomes were interrogated by tandem-affinity-purification and subsequent mass spectrometry. Our combined studies confirmed the pathogenicity of p.V231_I232del, p.G312R, and p.L457P by showing instability of the proteins as well as tendency to form aggregates. This observation is in line with altered structure of the ER-Golgi system and vacuole formation upon expression of these pathogenic SIL1-mutants as well as the presence of oxidative or ER-stress. Reduced cellular fitness along with abnormal mitochondrial architecture could also be observed. Notably, both the polymorphic p.K132Q and the ambiguous p.R92W variants did not elicit such alterations. Study of the SIL1-interactome identified POC1A as a novel binding partner of wild-type SIL1; the interaction is disrupted upon the presence of pathogenic mutants but not influenced by the presence of benign variants. Disrupted SIL1-POC1A interaction is associated with centrosome disintegration. We developed a combination of cellular outcome measures to evaluate the pathogenicity of variants in suitable models and demonstrated that the p. R92W missense variant is a polymorphism rather than a pathogenic mutation leading to MSS.
该基因中的隐性突变会导致 Marinesco-Sjögren 综合征(MSS),这是一种罕见的神经儿科疾病。MSS 患者通常表现为先天性白内障、智力残疾、小脑共济失调和进行性空泡性肌病。然而,在过去几年中已经描述了与该基因突变相关的非典型临床表现;SIL1 错义突变的复合杂合性甚至导致了一种不符合 MSS 临床诊断标准的表型。因此,需要一种读出系统来可靠地评估该基因中氨基酸变化的致病性。在这里,我们旨在提供合适的细胞生物标志物,以便能够有力地评估 SIL1 突变的致病性。通过细胞生物学测定、免疫沉淀、免疫印迹、免疫荧光以及电子显微镜,在 Hek293 模型中研究了五个该基因变体,包括一个多态性位点(p.K132Q)、三个已知的致病突变(p.V231_I232del、p.G312R 和 p.L457P)以及一个意义不明确的错义变体(p.R92W),同时还研究了野生型蛋白。此外,通过串联亲和纯化和后续质谱分析对 SIL1 相互作用组进行了探究。我们的综合研究通过显示蛋白质的不稳定性以及形成聚集体的倾向,证实了 p.V231_I232del、p.G312R 和 p.L457P 的致病性。这一观察结果与这些致病性 SIL1 突变体表达后内质网 - 高尔基体系统结构改变和液泡形成以及氧化应激或内质网应激的存在一致。还可以观察到细胞适应性降低以及线粒体结构异常。值得注意的是,多态性的 p.K132Q 和意义不明确的 p.R92W 变体均未引发此类改变。对 SIL1 相互作用组的研究确定 POC1A 是野生型 SIL1 的一种新的结合伴侣;在存在致病突变体时这种相互作用会被破坏,但不受良性变体存在的影响。SIL1 - POC1A 相互作用的破坏与中心体解体有关。我们开发了一组细胞结果测量方法来评估合适模型中该基因变体的致病性,并证明 p.R92W 错义变体是一种多态性而非导致 MSS 的致病突变。